Novartis is moving forward with collaboration on research and development of health products to promote Thai innovation for commercialization. They are joining a meeting to discuss commercial research with the Intellectual Property and Enterprise Development Center and the Faculty of Pharmacy, Thammasat University. The meeting is led by the center’s director, Dr. Anut Leemakdej, and also attended by the company’s representative, Mr. Thanat Polawatdon.
The company is determined to be a part of driving innovative health and pharmaceutical products for prevention, treatment, and cure, in order to promote a sustainable quality of life for Thai people.